stocktools
Offerings // Unicycive Therapeutics, Inc.

UNCY offering history

Every offering-related filing in Unicycive Therapeutics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 301 filings back to Mar 4, 2019.

Last executed offering
Nov 14, 2025
424B5 — priced deal (shares or notes)
Last registration (announced)
Jun 5, 2026
S-3 — capacity, not a sale
Executed, last 12 months
1
424B pricings + 8-K 3.02 sales
Registered, last 12 months
1
S-1/S-3/F-series registrations
DateFilingWhat it means
Jun 15, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jun 5, 2026S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Nov 14, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 13, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 20, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Nov 14, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Nov 13, 2024S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jul 16, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jul 16, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 5, 2024S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Mar 14, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Mar 14, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Aug 3, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 13, 2023S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Mar 6, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Aug 24, 2022EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Aug 16, 2022S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jul 14, 2021424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Jul 12, 2021S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jul 12, 2021S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jul 12, 2021EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jun 30, 2021S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jun 21, 2021S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jun 7, 2021S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
May 21, 2021S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
UNCY offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full UNCY workspace →
UNCY offering FAQ

When did UNCY last execute an offering?

Per SEC filings, Unicycive Therapeutics, Inc.'s most recent priced offering document is a 424B5 filed 2025-11-14. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did UNCY last announce or register an offering?

The most recent registration is a S-3 filed 2026-06-05. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.